Mette Friberg Hitz
Clinical Associate Professor
Department of Clinical Medicine
Blegdamsvej 3
2200 København N.
Member of:
Internal Medicine: Endocrinology
1 - 3 out of 3Page size: 500
- 2022
- Published
Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study
Bønløkke, S. E., Rand, M. S., Haddock, B., Arup, S., Smith, C. D., Jensen, Jens-Erik Beck, Schwarz, Peter, Hovind, P., Oturai, P. S., Jensen, Lars Thorbjørn, Møller, Søren, Eiken, P., Rubin, K. H., Hitz, Mette Friberg, Abrahamsen, B. & Jørgensen, Niklas Rye, 2022, In: Osteoporosis International. 33, p. 2155–2164Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effectiveness of patient education for patients with osteoporosis: a systematic review
Rubæk, M., Hitz, Mette Friberg, Holmberg, T., Schønwandt, B. M. T. & Andersen, S., 2022, In: Osteoporosis International. 33, 5, p. 959-977 19 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study
Matzen, J., Bislev, L. S., Sikjaer, T., Rolighed, L., Hitz, Mette Friberg, Eiken, P., Hermann, A. P., Jensen, Jens-Erik Beck, Abrahamsen, B. & Rejnmark, L., 2022, In: BMC Endocrine Disorders. 22, 1, 11 p., 14.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 33973150
Most downloads
-
58
downloads
Osteoporosis is associated with deteriorating clinical status in adults with cystic fibrosis
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
16
downloads
Postoperative Chronic Hypoparathyroidism and Quality of Life After Total Thyroidectomy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
16
downloads
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published